Updates in palliative care – overview and recent advancements in the pharmacological management of cancer pain
Authors:
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Clinical Medicine
- Vol. 18 (1) , 17-22
Abstract
Pain is a common symptom in many types of cancer. Interdisciplinary team management, including pain assessment, explanation to the patient/family, treating the reversible, non-pharmacological treatments and reassessment are essential. This article focuses on the pharmacological management of cancer pain, and overviews and updates on the recent advances in this field. Both non-opioid and opioid analgesia as well as coanalgesics (adjuvants) are reviewed. Within non-opioid analgesia the risks of non-steroidal anti-inflammatory drugs (NSAIDs) are considered and recommendations for NSAIDs in patients at risk of gastrointestinal and cardiovascular toxicity are made. For opioid analgesics, side effects of opioids are discussed alongside practical guidance on opioid prescribing and converting between opioids. Newer drugs such as tapentadol are considered in this update. Amitriptyline, duloxetine, gabapentin and pregabalin, and the guidance for their use are reviewed in the coanalgesics (adjuvants) section.Keywords
This publication has 44 references indexed in Scilit:
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsThe Lancet, 2013
- Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxoneClinical Medicine, 2013
- Guidance on the management of pain in older peopleAge and Ageing, 2013
- Differences between opioids: pharmacological, experimental, clinical and economical perspectivesBritish Journal of Clinical Pharmacology, 2012
- Treatment Guidelines for the Pharmacological Management of Pain in Older PersonsPain Medicine, 2012
- Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCThe Lancet Oncology, 2012
- A Comparative Efficacy of Amitriptyline, Gabapentin, and Pregabalin in Neuropathic Cancer PainAmerican Journal of Hospice and Palliative Medicine®, 2011
- The management of cancer‐related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and IrelandEuropean journal of pain, 2009
- Frequency, Indications, Outcomes, and Predictive Factors of Opioid Switching in an Acute Palliative Care UnitJournal of Pain and Symptom Management, 2009
- Pain Predicts Overall Survival in Men With Metastatic Castration-Refractory Prostate CancerJournal of Clinical Oncology, 2008